Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), By Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), By End User (Hospitals & Clinics and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 254.4 million in 2017, and is projected to exhibit a CAGR of 8.9% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.
Stem cell-based therapy is a key focus in functional replacement of cartilage regeneration. Increasing incidence of osteoarthritis among the global population is expected to increase adoption of efficient and promising treatment such as stem cell therapy during the forecast period.
For instance, according to the data findings published by Arthritis Foundation in November 2017, arthritis is the leading cause of disability among adults in the U.S., and over 53 million adults worldwide, suffer from arthritis, which refers to over 100 types of joint diseases. This number is projected to increase by 49% to reach over 78.4 million by 2040.
Furthermore, growing engagement of key players in developing stem cell therapy as commercially viable, safe, efficient, and economical therapeutic agents for cartilage regeneration is expected to drive growth of the global stem cell cartilage regeneration market
Organizations such as California’s Stem Cell Agency is indulged in the development of new stem cell-based therapies for chronic diseases such as cancer and rare diseases. For instance, manufacturers such as Sangamo Therapeutics and Fate Therapeutics are working on stem cell-based therapies for diseases such as β-Thalassemia and cancer, respectively
Companies are also focusing on research and development activities in order to launch novel products to increase its revenue in the stem cell cartilage regeneration market. According to Alliance for Regenerative Medicine, globally there were 946 clinical trials in progress in 2017, an 18% increase over the previous year.
Browse 42 Market Data Tables and 21 Figures spread through 154 Pages and in-depth TOC on "Stem Cell Cartilage Regeneration Market, By Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), By Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), By End User (Hospitals & Clinics, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
To know the latest trends and insights related to Stem Cell Cartilage Regeneration market, click the link below:
Key Takeaways of the Stem Cell Cartilage Regeneration Market:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.